Kontigo Care AB (publ) (KONT.ST)
SEK 2.64
(-1.49%)
SEK 2.64
(-1.49%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.67 Million SEK | 0.0% |
| 2022 | - SEK | -100.0% |
| 2021 | 1078.00 SEK | -99.8% |
| 2020 | 539.81 Thousand SEK | -60.6% |
| 2019 | 1.37 Million SEK | -24.23% |
| 2018 | 1.8 Million SEK | -27.91% |
| 2017 | 2.5 Million SEK | -12.24% |
| 2016 | 2.85 Million SEK | 880.01% |
| 2015 | 291.66 Thousand SEK | -38.24% |
| 2014 | 472.22 Thousand SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3.15 Million SEK | -14.29% |
| 2024 Q2 | 2.5 Million SEK | -20.38% |
| 2023 Q3 | 4.43 Million SEK | -10.59% |
| 2023 Q2 | 4.95 Million SEK | -16.67% |
| 2023 Q1 | 5.95 Million SEK | 0.0% |
| 2023 FY | 3.67 Million SEK | 0.0% |
| 2023 Q4 | 3.67 Million SEK | -17.1% |
| 2022 Q3 | - SEK | 0.0% |
| 2022 Q1 | - SEK | -100.0% |
| 2022 Q2 | - SEK | 0.0% |
| 2022 Q4 | - SEK | 0.0% |
| 2022 FY | - SEK | -100.0% |
| 2021 Q1 | 332 Thousand SEK | -38.5% |
| 2021 FY | 1078.00 SEK | -99.8% |
| 2021 Q3 | 34 Thousand SEK | -72.8% |
| 2021 Q4 | 1078.00 SEK | -96.83% |
| 2021 Q2 | 125 Thousand SEK | -62.35% |
| 2020 Q1 | 1.16 Million SEK | -15.12% |
| 2020 FY | 539.81 Thousand SEK | -60.6% |
| 2020 Q2 | 955 Thousand SEK | -17.88% |
| 2020 Q3 | 747 Thousand SEK | -21.78% |
| 2020 Q4 | 539.81 Thousand SEK | -27.74% |
| 2019 Q3 | 1.57 Million SEK | -11.6% |
| 2019 Q1 | 1.99 Million SEK | 10.21% |
| 2019 Q4 | 1.37 Million SEK | -13.17% |
| 2019 Q2 | 1.78 Million SEK | -10.44% |
| 2019 FY | 1.37 Million SEK | -24.23% |
| 2018 Q2 | 2.15 Million SEK | -7.5% |
| 2018 FY | 1.8 Million SEK | -27.91% |
| 2018 Q4 | 1.8 Million SEK | -8.81% |
| 2018 Q3 | 1.98 Million SEK | -8.11% |
| 2018 Q1 | 2.33 Million SEK | -6.99% |
| 2017 Q1 | 2.8 Million SEK | -2.04% |
| 2017 FY | 2.5 Million SEK | -12.24% |
| 2017 Q4 | 2.5 Million SEK | -12.23% |
| 2017 Q3 | 2.85 Million SEK | 2.07% |
| 2017 Q2 | 2.8 Million SEK | 0.0% |
| 2016 FY | 2.85 Million SEK | 880.01% |
| 2016 Q4 | 2.85 Million SEK | -22.05% |
| 2016 Q3 | 3.66 Million SEK | -1.11% |
| 2016 Q2 | 3.7 Million SEK | -1.12% |
| 2016 Q1 | 3.75 Million SEK | 1185.72% |
| 2015 FY | 291.66 Thousand SEK | -38.24% |
| 2015 Q4 | 291.66 Thousand SEK | -12.41% |
| 2015 Q3 | 333 Thousand SEK | -13.51% |
| 2015 Q2 | 385 Thousand SEK | 0.0% |
| 2015 Q1 | - SEK | -100.0% |
| 2014 FY | 472.22 Thousand SEK | 0.0% |
| 2014 Q4 | 472.22 Thousand SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aino Health AB (publ) | 164 Thousand SEK | -2140.854% |
| Bonzun AB (publ) | 554 Thousand SEK | -563.357% |
| Medhelp Care Aktiebolag (publ) | - SEK | -Infinity% |
| RaySearch Laboratories AB (publ) | 431.97 Million SEK | 99.149% |
| Surgical Science Sweden AB (publ) | 40.02 Million SEK | 90.818% |